Lupin Limited

LUPIN NSE Healthcare Pharmaceuticals
Nifty 200 Nifty 500 Midcap 50 Midcap 100 Midcap 150 LargeMid 250 F&O
₹2,095.00
+0.83%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.29.
  • Comfortable interest cover: operating profit covers interest about 18.8 times.
  • Return on equity is healthy at 28.7%.
  • Return on capital employed is healthy at 29.9%.
  • Net profit margin is strong at 19.2%.
  • Profit has compounded about 37% a year over five years.
  • Sales have compounded about 13% a year over five years.
  • Pays a dividend (yield about 0.85%).
  • Has paid a dividend in 4 of the last 5 years.
  • Promoters hold a sizeable stake (46.85%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.78

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
6 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 95,797 Cr
Current Price₹ 2,095.00
High / Low₹ 2,529.50 / 1,900.00
Stock P/E17.354208
Book Value₹ 491.00
Dividend Yield0%
ROCE29.90%
ROE28.70%
Face Value₹ 2.00
Debt to Equity0.29
PEG Ratio0.12
EV / EBITDA10.81
Industry PE35.25
P/B Ratio4.266655
EPS₹ 116.65
Debt₹ 6,616 Cr
PAT Margin19.15%
Cash PAT₹ 6,731 Cr
ICR18.80
Promoter Holding46.85%
FII Holding22.42%
DII Holding24.65%
Public Holding6.08%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 7.00%
5 Years 13.00%
3 Years 19.00%
TTM 28.00%
Compounded Profit Growth
10 Years 10.00%
5 Years 37.00%
3 Years 140.00%
TTM 61.00%
Stock Price CAGR
10 Years 3.00%
5 Years 17.00%
3 Years 23.00%
1 Year 9.00%
Return on Equity
10 Years 10.00%
5 Years 13.00%
3 Years 22.00%
Last Year 29.00%
Educational data only. Not a recommendation to buy, sell or hold any security.